This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| tryptamine | |
|---|---|
| Name | Tryptamine |
| Caption | Structural formula of tryptamine |
| Iupac name | 2-(1H-indol-3-yl)ethanamine |
| Formula | C10H12N2 |
| Molar mass | 160.22 g·mol−1 |
| Melting point | 26–30 °C |
| Density | 1.13 g·cm−3 |
tryptamine Tryptamine is a monoamine alkaloid derived from the amino acid L-tryptophan and characterized by an indole ring linked to an aminoethyl side chain. As a simple biogenic scaffold, it serves as a biosynthetic precursor and structural core for numerous endogenous neuromodulators, plant allelochemicals, fungal metabolites, and synthetic psychoactive agents. Its physicochemical properties and reactivity underlie roles in biochemistry pathways studied by researchers at institutions such as Max Planck Society, National Institutes of Health, Harvard University, and University of Oxford.
The tryptamine scaffold comprises an indole aromatic system fused from a benzene and pyrrole ring, attached at the 3-position to an ethylamine moiety; analyses employ techniques developed at Royal Society, American Chemical Society, Deutsches Elektronen-Synchrotron, and laboratories led by figures like Linus Pauling and Robert Burns Woodward. Crystallographic characterization often references methodologies from International Union of Crystallography and instrumentation at European Synchrotron Radiation Facility, while spectral assignments draw on standards from Chemical Abstracts Service and databases curated by National Center for Biotechnology Information. Chemical reactions converting the indolic core include electrophilic substitution, reductive amination, and N-alkylation, methods refined in the context of synthetic programs at Massachusetts Institute of Technology, Stanford University, and ETH Zurich.
Tryptamine occurs endogenously in animals, plants, fungi, and bacteria, with biosynthetic conversion from L-tryptophan via aromatic amino acid decarboxylases studied in contexts involving Carnegie Institution for Science, Max Planck Institute for Chemical Ecology, and researchers such as Alexander Fleming-era microbiologists. In plants like those researched at Royal Botanic Gardens, Kew and commercial cultivars documented by Food and Agriculture Organization, tryptamine derivatives participate in secondary metabolism related to alkaloid pathways mapped by groups at Salk Institute and John Innes Centre. Microbial producers and gene clusters are frequently characterized using genomics platforms at Broad Institute and sequencing centers like Wellcome Sanger Institute.
As a trace amine, tryptamine modulates neurophysiology by interacting with trace amine-associated receptors (TAARs) and monoaminergic systems; seminal receptor pharmacology has been advanced at Columbia University, UCL, and pharmaceutical research centers including Pfizer and GlaxoSmithKline. Its capacity to act as a partial agonist or ligand at serotonin receptor subtypes (notably 5-HT receptors) links it to work by investigators at National Institute of Mental Health and clinical research at Johns Hopkins University. Mechanistic studies deploy techniques from Cold Spring Harbor Laboratory, electrophysiology protocols developed at MIT, and imaging approaches used at Mayo Clinic and Massachusetts General Hospital.
Natural derivatives include indole alkaloids found in species cataloged by Kew Gardens and metabolites like melatonin biosynthesized via N-acetylation, researched at Karolinska Institutet and University of California, San Diego. Plant- and fungus-derived tryptamines, such as those isolated from genera examined by Royal Botanic Gardens, Kew and mycology programs at Field Museum, have inspired synthetic analogs produced in medicinal chemistry labs at Yale University, University of Cambridge, and pharmaceutical companies like Novartis. Well-known synthetic derivatives that share the tryptamine core have been studied in pharmacology departments at University of California, San Francisco and regulatory reviews by World Health Organization panels.
Biotransformation of tryptamine involves monoamine oxidase (MAO) enzymes characterized by researchers at Pasteur Institute and Karolinska Institutet, producing metabolites which have been profiled using mass spectrometry facilities at Argonne National Laboratory and European Molecular Biology Laboratory. Toxicological assessment appears in toxicology units at United States Environmental Protection Agency and occupational medicine research at Imperial College London, with safety profiling guided by committees such as those convened by European Medicines Agency and Food and Drug Administration. Case reports and poison center data analyzed by networks coordinated through World Health Organization inform limits on exposure and clinical management.
Tryptamine chemistry and its derivatives played roles in 20th-century psychopharmacology, a field shaped by figures and institutions like Albert Hofmann, Sandoz Laboratories, Heffter Research Institute, Harvard University psychiatric research programs, and conferences at Royal Society of Medicine. Ethnobotanical uses of tryptamine-containing plants intersect with traditions preserved by indigenous communities studied in anthropological work at Smithsonian Institution and recorded by ethnopharmacologists at University of British Columbia. Cultural debates about psychedelics and research policy have involved stakeholders including Multidisciplinary Association for Psychedelic Studies, Brookings Institution, and lawmakers such as those serving in United States Congress and parliaments worldwide.
Regulatory status of tryptamine derivatives varies by jurisdiction, with scheduling and control measures enacted by agencies such as Drug Enforcement Administration, European Monitoring Centre for Drugs and Drug Addiction, Home Office (United Kingdom), and national legislatures including Parliament of the United Kingdom and United States Congress. International controls and treaty frameworks involve entities like United Nations Office on Drugs and Crime and deliberations at meetings of the World Health Organization Expert Committee on Drug Dependence. Research licenses and compliance obligations are administered by institutional review boards at universities such as Yale University School of Medicine, University of California campuses, and governmental regulators including Health Canada.
Category:Alkaloids Category:Indole compounds